SK282056B6 - Spôsob zlepšenia organoleptických vlastností mäsa nevykastrovaných samcov domácich zvierat - Google Patents

Spôsob zlepšenia organoleptických vlastností mäsa nevykastrovaných samcov domácich zvierat Download PDF

Info

Publication number
SK282056B6
SK282056B6 SK3280-92A SK328092A SK282056B6 SK 282056 B6 SK282056 B6 SK 282056B6 SK 328092 A SK328092 A SK 328092A SK 282056 B6 SK282056 B6 SK 282056B6
Authority
SK
Slovakia
Prior art keywords
lhrh
vaccine
administered
globulin
equine
Prior art date
Application number
SK3280-92A
Other languages
English (en)
Slovak (sk)
Other versions
SK328092A3 (en
Inventor
Raymond Dufour
Claude Roulet
Claire Chouvet
Michel Bernard Bonneau
Original Assignee
Merial
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26228546&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK282056(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9102513A external-priority patent/FR2673377B1/fr
Priority claimed from FR9115289A external-priority patent/FR2685333B1/fr
Application filed by Merial filed Critical Merial
Publication of SK328092A3 publication Critical patent/SK328092A3/sk
Publication of SK282056B6 publication Critical patent/SK282056B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SK3280-92A 1991-03-01 1992-02-26 Spôsob zlepšenia organoleptických vlastností mäsa nevykastrovaných samcov domácich zvierat SK282056B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9102513A FR2673377B1 (fr) 1991-03-01 1991-03-01 Procede pour ameliorer les qualites organoleptiques des animaux domestiques non castres.
FR9115289A FR2685333B1 (fr) 1991-12-10 1991-12-10 Nouveau peptide notamment pour la realisation de conjugues immunogenes anti-lhrh, vaccins les incorporant et ensemble de vaccination y relatif.
PCT/FR1992/000176 WO1992015330A1 (fr) 1991-03-01 1992-02-26 Procede d'immunoneutralisation anti-lhrh des animaux domestiques males non castres et peptide pour cela

Publications (2)

Publication Number Publication Date
SK328092A3 SK328092A3 (en) 1995-01-05
SK282056B6 true SK282056B6 (sk) 2001-10-08

Family

ID=26228546

Family Applications (1)

Application Number Title Priority Date Filing Date
SK3280-92A SK282056B6 (sk) 1991-03-01 1992-02-26 Spôsob zlepšenia organoleptických vlastností mäsa nevykastrovaných samcov domácich zvierat

Country Status (19)

Country Link
US (1) US5573767A (ja)
EP (1) EP0501882B1 (ja)
JP (1) JP3177246B2 (ja)
KR (1) KR100257214B1 (ja)
AT (1) ATE194625T1 (ja)
CA (1) CA2081660C (ja)
CZ (1) CZ287775B6 (ja)
DE (1) DE69231232T2 (ja)
DK (1) DK0501882T3 (ja)
ES (1) ES2149166T3 (ja)
GR (1) GR3034509T3 (ja)
HU (1) HU214453B (ja)
IE (1) IE920648A1 (ja)
PL (1) PL296623A1 (ja)
PT (1) PT501882E (ja)
SK (1) SK282056B6 (ja)
TW (1) TW221674B (ja)
UA (1) UA40570C2 (ja)
WO (1) WO1992015330A1 (ja)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688506A (en) 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
US6761890B1 (en) * 1995-06-07 2004-07-13 Pepscan Systems B.V. Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
CU22627A1 (es) * 1996-12-17 2000-12-22 Ct Ingenieria Genetica Biotech Preparado vacunal para la inmuno-castración reversible de mamíferos
AUPO776897A0 (en) 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
US6524592B2 (en) * 1997-10-17 2003-02-25 American Home Products Corporation Veterinary vaccines
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US7790856B2 (en) 1998-04-07 2010-09-07 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize beta amyloid peptide
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
WO1999056771A2 (en) * 1998-05-05 1999-11-11 Biostar Inc. Methods of raising animals for meat production
ATE285806T1 (de) 1999-10-11 2005-01-15 Felton International Inc Universelle antiinfektionsschutzvorrichtung für nadellose injektoren
US7887506B1 (en) 1999-11-23 2011-02-15 Pulse Needlefree Systems, Inc. Safety mechanism to prevent accidental patient injection and methods of same
US6770054B1 (en) 1999-11-23 2004-08-03 Felton International, Inc. Injector assembly with driving means and locking means
MY139983A (en) 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
WO2003089590A2 (en) * 2002-04-16 2003-10-30 Vaxin, Inc. TRANSIENT AND/OR PERMANENT MODIFICATION OF SEXUAL BEHAVIOR AND/OR FERTILITY USING RECOMBINANT CHIMERIC GnRH
CN1777439A (zh) 2003-04-22 2006-05-24 研究及应用科学协会股份有限公司 生长抑素的载体
JP2005098877A (ja) * 2003-09-25 2005-04-14 Hitachi Software Eng Co Ltd 抗体検出体、その製造方法、及び抗体検出方法
JP2008512396A (ja) * 2004-09-10 2008-04-24 ザ・カウンシル・オブ・ザ・クィーンズランド・インスティテュート・オブ・メディカル・リサーチ 切断型ｌｈｒｈ製剤
WO2006066089A1 (en) 2004-12-15 2006-06-22 Neuralab Limited Humanized amyloid beta antibodies for use in improving cognition
KR100701550B1 (ko) * 2005-05-24 2007-03-30 한국과학기술연구원 베어링리스 스텝모터
US8784810B2 (en) 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
JP5752343B2 (ja) * 2007-01-24 2015-07-22 株式会社ココカラファインネクスト Ｓ／ｏ型経皮免疫剤
US8003097B2 (en) 2007-04-18 2011-08-23 Janssen Alzheimer Immunotherapy Treatment of cerebral amyloid angiopathy
PL2182983T3 (pl) 2007-07-27 2014-10-31 Janssen Alzheimer Immunotherap Leczenie chorób amyloidowych z wykorzystaniem humanizowanych przeciwciał specyficznych względem Abeta
JO3076B1 (ar) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
US20140123330A1 (en) * 2012-10-30 2014-05-01 Recombinetics, Inc. Control of sexual maturation in animals
US10920242B2 (en) 2011-02-25 2021-02-16 Recombinetics, Inc. Non-meiotic allele introgression
US9669085B2 (en) 2011-06-01 2017-06-06 Merial Inc. Needle-free administration of PRRSV vaccines

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024121A (en) * 1976-01-27 1977-05-17 Schally Andrew Victor (Pyro)-Glu-His-Trp-D-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHR and intermediates
US4018726A (en) * 1975-06-12 1977-04-19 Andrew Victor Schally [D-Phe6 ]-LH-RH and intermediates therefor
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4770874A (en) * 1983-08-22 1988-09-13 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4676981A (en) * 1984-02-07 1987-06-30 University Of Saskatchewan Monoclonal antibodies against GnRH
US4608251A (en) * 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
US4556555A (en) * 1985-01-25 1985-12-03 North Carolina State University Process for the immunological neutering of animals
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
JPH01500663A (ja) * 1986-08-18 1989-03-09 バンジ・（オーストラリア）・プロプライアタリー・リミテッド 動物の生殖機能の調節
AU602187B2 (en) * 1987-01-14 1990-10-04 Commonwealth Scientific And Industrial Research Organisation Anti-reproductive hormone
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
US4975420A (en) * 1987-09-30 1990-12-04 University Of Saskatchewan Agents and procedures for provoking an immune response to GnRH and immuno sterilizing mammals
US5036047A (en) * 1988-09-29 1991-07-30 Pitman-Moore, Inc. Method and composition for preventing conception
US5484592A (en) * 1989-03-23 1996-01-16 Stitching Centraal Diergeneeskundig Instituut Peptide, immunogenic composition and vaccine or medicinal preparation: a method of immunising a mammal against LHRH, and a method of improving the meat quality of pigs
NL8900726A (nl) * 1989-03-23 1990-10-16 Stichting Centr Diergeneeskund Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.

Also Published As

Publication number Publication date
GR3034509T3 (en) 2000-12-29
JP3177246B2 (ja) 2001-06-18
HU214453B (hu) 1998-03-30
EP0501882A2 (fr) 1992-09-02
CA2081660C (en) 2001-05-01
PT501882E (pt) 2000-12-29
HU9203419D0 (en) 1993-01-28
CZ328092A3 (en) 1993-10-13
PL296623A1 (en) 1993-09-20
TW221674B (ja) 1994-03-11
HUT63338A (en) 1993-08-30
DE69231232T2 (de) 2001-01-04
ES2149166T3 (es) 2000-11-01
CZ287775B6 (cs) 2001-01-17
DE69231232D1 (de) 2000-08-17
SK328092A3 (en) 1995-01-05
KR100257214B1 (ko) 2000-05-15
IE920648A1 (en) 1992-09-09
JPH05506459A (ja) 1993-09-22
EP0501882A3 (en) 1992-10-14
US5573767A (en) 1996-11-12
DK0501882T3 (da) 2000-12-11
CA2081660A1 (en) 1992-09-02
EP0501882B1 (fr) 2000-07-12
WO1992015330A1 (fr) 1992-09-17
UA40570C2 (uk) 2001-08-15
ATE194625T1 (de) 2000-07-15

Similar Documents

Publication Publication Date Title
SK282056B6 (sk) Spôsob zlepšenia organoleptických vlastností mäsa nevykastrovaných samcov domácich zvierat
Thompson Jr Immunization against GnRH in male species (comparative aspects)
IE83361B1 (en) A method for improving the organoleptic qualities of meat
Bonneau et al. Immunocastration in cattle and pigs
US4608251A (en) LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
RU2147307C1 (ru) Улучшенный пептид, иммуногенная композиция и вакцина с его использованием, способ иммунизации животных против гормона лгвг
AU622858B2 (en) Biologically active molecules
TW201603821A (zh) 免疫性ｌｈｒｈ組成物及其於豬隻之應用
AU625561B2 (en) Method and composition for preventing conception
EP0274496A1 (en) Composition and method for immunological castration and spaying
US6783761B2 (en) Chimeric peptide immunogens
JPH01301696A (ja) ペプチド構造体、それらを含む免疫原及び妊性の調節へのそれらの使用
Ayalew A review on the effect of immunocastration against gonadal physiology and boar taint.
CZ289521B6 (cs) Anti-LHRH vakcinační souprava pro výrobu masa se zlepąenými organoleptickými vlastnostmi, získávaného z nevykastrovaných samců domácích zvířat
US5401829A (en) Biologically active molecules
Turkstra et al. Active immunisation against gonadotropin-releasing hormone, an active tool to block the fertility axis in mammals
NZ196126A (en) Increasing ovulation rate in female cattle
EP0072880B1 (en) A composition for use in the control of ovulation of female bovines
AU7642387A (en) Composition and method for immunological castration and spaying
Hage-van Noort et al. Immunomodulation of reproductive systems
FR2685333A1 (fr) Nouveau peptide notamment pour la realisation de conjugues immunogenes anti-lhrh, vaccins les incorporant et ensemble de vaccination y relatif.
Mia Overview: Contraceptive Vaccines for Humans and Animals
NO880918L (no) Preparat og metode for immunologisk kastrering og sterilisering.

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20120226